TSHA NASDAQ
Taysha Gene Therapies, Inc.
1W: -12.1%
1M: -17.6%
3M: +17.9%
YTD: +5.5%
1Y: +89.1%
3Y: +700.6%
5Y: -73.5%
$5.49
-0.05 (-0.90%)
Weekly Expected Move ±8.1%
$5
$5
$6
$6
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$7M
Revenue
+3.4% YoY
$-130M
Net Income
-49.7% YoY
$-112M
Free Cash Flow
-33.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-81.6%
ROA-51.6%
ROIC191.6%
Valuation
P/E-15.5
P/B9.5
EV/EBITDA-10.3
Leverage
Debt/Equity0.07
Current Ratio12.23
Interest Cov.-2478.7x
Quality Scores
Piotroski F4/9
Altman Z7.10
Beneish M0.00